Could cause temporary or reversible harm; serious harm is unlikely.
Failed tablet specifications.
| Brand name | MECLIZINE HYDROCHLORIDE |
| Generic name | MECLIZINE HYDROCHLORIDE |
| Active ingredient(s) | MECLIZINE HYDROCHLORIDE |
| Distributed by / for | American Health Packaging, Columbus, Ohio, 43217 |
| NDC | 60687-775-65 |
| Full product label | Meclizine Hydrochloride Tablets, USP 12.5 mg, (a) 50 Tablets [5 x 10] (NDC 60687-775-65) (b) 12.5 mg Individual Dose ( NDC 60687-775-11), Rx Only, Distributed by: American Health Packaging, Columbus, Ohio, 43217. |
| Recalling firm | Amerisource Health Services LLC |
| Distribution | U.S. Nationwide |
| Quantity | 697 cartons |
| Recall initiated | 2026-03-16 |
| Report date | 2026-04-01 |
| Recall completed | — |
| Recall number | D-0418-2026 |
| Classification | Class II |
| FDA status | Ongoing |
| Origin on file | Columbus OH United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗